Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

[Potentials risks in drug prevention of thrombosis--low-molecular-weight heparin versus standard heparin].

Ganzer D, Gutezeit A, Mayer G.

Z Orthop Ihre Grenzgeb. 1999 Sep-Oct;137(5):457-61. German.

PMID:
10549126
2.

[Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].

Ganzer D, Gutezeit A, Mayer G, Greinacher A, Eichler P.

Z Orthop Ihre Grenzgeb. 1997 Nov-Dec;135(6):543-9. German.

PMID:
9499523
4.

[Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].

Marx A, Huhle G, Hoffmann U, Wang LC, Schüle B, Jani L, Harenberg J.

Z Orthop Ihre Grenzgeb. 1999 Nov-Dec;137(6):536-9. German.

PMID:
10666863
5.
6.

[Heparin induced thrombocytopenia type II after the use of low-molecular weight heparin. Case report and review of the literature].

Franke J, Schaeper O, Kayser R, Mahlfeld K.

Unfallchirurg. 2003 Jan;106(1):77-81. German.

PMID:
12552397
7.

[Significance and incidence of type II heparin-induced thrombocytopenia. A prospective study].

Mahlfeld K, Böck M, Franke J, Meinecke I, Schaeper O, Kayser R, Grasshoff H.

Zentralbl Chir. 2001 Jan;126(1):39-43. German.

PMID:
11227292
8.

[Heparin induced thrombocytopenia. A frequently unrecognised complication after major orthopedic surgery].

Picker SM, Gathof BS.

Orthopade. 2004 Nov;33(11):1300-8. Review. German.

PMID:
15278277
9.

[Standards and perspectives for thromboembolism prophylaxis].

Rader CP.

Orthopade. 2007 Jun;36(6):560, 562-6. Review. German.

PMID:
17546440
11.

Clinical relevance of heparin-PF4 complex antibody in DVT after total joint replacement.

Torigoshi T, Motokawa S, Maeda Y, Maeda K, Hiura T, Takayama G, Taguchi K, Shindo H, Migita K.

BMC Musculoskelet Disord. 2009 Apr 28;10:42. doi: 10.1186/1471-2474-10-42.

13.

The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia.

Lubenow N, Hinz P, Thomaschewski S, Lietz T, Vogler M, Ladwig A, Jünger M, Nauck M, Schellong S, Wander K, Engel G, Ekkernkamp A, Greinacher A.

Blood. 2010 Mar 4;115(9):1797-803. doi: 10.1182/blood-2009-07-231506.

14.

Prevention of thromboembolism with low-molecular-weight heparin in orthopedic surgery: a 5-year experience.

Wenzl ME, Hasse W, Seide K, Wolter D.

Clin Appl Thromb Hemost. 2004 Jan;10(1):1-4.

PMID:
14979398
15.

[Prevention of thrombosis with unfractionated and low molecular weight heparin].

Breddin HK.

Wien Med Wochenschr. 1989 Dec 15;139(23):555-9. Review. German.

PMID:
2560285
16.
17.

Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies.

Ahmad S, Haas S, Hoppensteadt DA, Lietz H, Reid U, Bender N, Messmore HL, Misselwitz F, Bacher P, Gaikwad BS, Jeske WP, Walenga JM, Fareed J.

Thromb Res. 2002 Oct 1;108(1):49-55.

PMID:
12586132
18.

Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).

Haas S, Breyer HG, Bacher HP, Fareed J, Misselwitz F, Victor N, Weber J; ECHOS Trial Group..

Int Angiol. 2006 Dec;25(4):335-42.

PMID:
17164738
19.

An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.

Warkentin TE, Roberts RS, Hirsh J, Kelton JG.

Arch Intern Med. 2003 Nov 10;163(20):2518-24.

PMID:
14609790
20.

[Heparin-induced thrombocytopenia type II].

Eder S, Hamann H.

Chirurg. 1999 Oct;70(10):1149-55. German.

PMID:
10550346
Items per page

Supplemental Content

Support Center